5
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T81517 |
PEP1
|
||
PEP1为具生物活性的肽类化合物。它在低浓度时能够与POPC SLB结合,在高浓度下则会引起POPC SLB的裂解。 | |||
TP2196 |
Pep1-AGL
|
Others | Others |
Analog of Pep1-TGL | |||
TP2197 |
Pep1-TGL
|
Others | Others |
Peptide containing the 'TGL' motif that corresponds to the C-terminus of GluR1 subunit | |||
TP1798 |
Pep-1 (uncapped)
Pep-1 uncapped |
Others | Others |
Pep-1 (uncapped) 是一种能够透过细胞的多肽。 | |||
T76273 |
Pep19-2.5
|
||
Pep19-2.5为合成抗毒素肽,能阻断内毒素信号级联。通过抑制跨膜及胞质模式识别受体(PRRs)介导的脂肽(LP)与脂多糖(LPS)的信号通路,Pep19-2.5关键调控与炎症及细胞焦亡(pyroptosis)相关的信号级联。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01739 |
CNDP2 Protein, Mouse, Recombinant (His)
C76600,Dip-2,Pep-1,Cn2,061001... |
Mouse | Baculovirus Insect Cells |
CNDP2 Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 54.22 kDa and the accession number is Q9D1A2. | |||
TMPJ-01351 |
XPNPEP1 Protein, Human, Recombinant (His)
Xaa-Pro Aminopeptidase 1,X-Prolyl Amino |
Human | E. coli |
X-Prolyl Aminopeptidase (XPNPEP1) is a proline-specific metalloaminopeptidase that specifically catalyzes the removal of any unsubstituted N-terminal amino acid that is adjacent to a penultimate proline residue. Because of its specificity toward proline, it has been suggested that X-Prolyl Aminopeptidase is important in the maturation and degradation of peptide hormones, neuropeptides, and tachykinins, as well as in the digestion of otherwise resistant dietary protein fragments, thereby compleme... | |||
TMPY-03329 |
DPEP1 Protein, Human, Recombinant (His)
MBD1,dipeptidase 1,MDP,RDP |
Human | HEK293 Cells |
Dehydropeptidase-I, also known as DPEP1, is a kidney membrane enzyme. Its expression in normal colonic mucosa is very low, but it is highly expressed in colorectal adenoma and cancer specimens and is negatively correlated with parameters of pathological aggressiveness and poor prognosis. The overexpression of DPEP1 suppressed tumor cells invasiveness and increased sensitivity to chemotherapeutic agent Gemcitabine. Growth factor EGF treatment decreased DPEP1 expression. Dehydropeptidase-I m... |